CRISPR-Cas9 screening identifies KRAS-induced COX2 as a driver of immunotherapy resistance in lung cancer.
收藏DataCite Commons2026-01-02 更新2026-05-05 收录
下载链接：
https://crick.figshare.com/articles/dataset/CRISPR-Cas9_screening_identifies_KRAS-induced_COX2_as_a_driver_of_immunotherapy_resistance_in_lung_cancer_/30988024/1
下载链接
链接失效反馈官方服务：
资源简介：
Datasets associated with CRISPR-Cas9 screening identifies KRAS-induced COX2 as a driver of immunotherapy resistance in lung cancer. Boumelha, J., de Castro, A., Bah, N., Cha, H., de Carné Trécesson, S., Rana, S., ... & Downward, J. (2024). CRISPR–Cas9 screening identifies KRAS-induced COX2 as a driver of immunotherapy resistance in lung cancer. <i>Cancer research</i>, <i>84</i>(14), 2231-2246.
提供机构：
The Francis Crick Institute
创建时间：
2026-01-02
